Cochrane · systematic review · CD012436

Drug interventions for the treatment of obesity in children and adolescents

Axon, E, Atkinson, G, Richter, B, et al. · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

Metabolic and Endocrine DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
5
No studies
1
Included studies
NR
No studies 1 · 16.7%Ungraded 0 · 0%Very low 0 · 0%Low 4 · 66.7%Moderate 1 · 16.7%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Drug interventions for the treatment of obesity in children and adolescents

Population: obese children and adolescents
6 questions
OutcomeEffectEvidenceStatus / GRADE
a. BMI (kg/m2)
no estimate extracted16 studies · 1884 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Adverse events a. Serious adverse events b. Discontinuation of trial because of adverse events
RR 1.43 [0.63, 3.25]5 studies · 1347 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Health‐related quality of life 3 questionnaires (1 trial) and SF‐36 (1 trial)
no estimate extracted2 studies · 86 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
All‐cause mortality
no estimate extracted20 studies · 2176 participantsModerate
Downgraded: risk of bias, imprecision, inconsistency
Morbidity
no estimate extracted1 study · 533 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Socioeconomic effects
no estimate extractedNRNo studies